Regina E. Groves
Independent DirectorMs. Regina E. Groves, also known as Reggie, serves as Director of Brixton Biosciences, Inc. since May 2024. She serves as Non-Employee Director of Fulgent Genetics, Inc. since January 3, 2023. She served as Chief Executive Officer of REVA Medical, Inc. since September 23, 2015 until March 2019. She serves as Director at Advanced NanoTherapies, Inc. Ms. Groves had been Executive Director of Stimwave Technologies, Inc. since July 2019 until December 2022. She was the Chief Financial Officer and Chief Operating Officer of Stimwave Technologies, Inc. from September 2019 to December 2020. From September 2015 to March 2019, Ms. Groves was the Chief Executive Officer at REVA Medical, Inc. Ms. Groves served as Vice President and General Manager of the AF Solutions, Cardiac Rhythm and Heart Failure division of Medtronic. In this position, she successfully developed and executed strategies to re-enter the catheter-based Atrial Fibrillation ablation market and achieved the goal to be market leader in paroxysmal, or intermittent, AF ablation. The role also allowed her to successfully acquire and integrate companies, complete numerous clinical trials and launch novel products in the U.S. and worldwide. Prior to, she served as the Vice President of Quality and Regulatory for Medtronic's Cardiac Rhythm Disease Management (CRDM) business from 2006 to 2008. Prior to, she served as Vice President and General Manager for Patient Management CRDM at Medtronic from 2002 to 2006. She also has extensive experience in strategic business consulting, including significant strategy development and M&A engagements for McKinsey & Company, Inc. and Kaiser Permanente. Her background also includes significant involvement with start-up companies and direct financial planning and reporting in numerous aspects of health care, including direct providers. She has more than three decades experience in medical devices, executive leadership and financial management. She serves as a Director of Advanced NanoTherapies, Incorporated and Stimwave Limited Liability Company. She served as Director of REVA Medical, Inc. since June 1, 2017 until March 2019. She has been an Independent Director of AtriCure, Inc. since March 21, 2017. She serves on the board of three private companies. She has been the recipient of numerous awards and honors, including being named as Women Changemaker by The Business Journal, Minneapolis, in July 2003. Ms. Groves received her MBA from Harvard Graduate School of Business Administration, with distinction after receiving her BS in Pharmacy with high honors from the University of Florida.
Positions
- Company NameAtriCure, Inc.Stock CodeATRCPositionIndependent DirectorColleagues
- MHMichael H. CarrelCEO, President & Director
- RSRobert S. WhiteIndependent Chairman of the Board
- ALAngela L. WirickChief Financial Officer
- DJDouglas J. SeithChief Operating Officer
- SPSalvatore PriviteraChief Technical Officer
- JJJustin J. NozneskyChief Marketing & Strategy Officer
- SASven A. WehrweinIndependent Director
- KNKaren N. PrangeIndependent Director
- Company NameFulgent Genetics, Inc.Stock CodeFLGTPositionIndependent Non-Employee DirectorColleagues
- MHMing HsiehChairman & CEO
- JXJian XieCOO & President
- PKPaul KimChief Financial Officer
- HGHanlin GaoChief Scientific Officer & Lab Director
- NPNatalie PrescottGeneral Counsel & Chief Privacy Officer
- LDLinda DongIndependent Director
- MNMichael NohaileIndependent Non-Employee Director
- RERegina E. GrovesIndependent Non-Employee Director
